SUNPHARMA vs ZYDUSLIFE: Stock Comparison

Head-to-head financial and trading comparison between Sun Pharmaceutical Industries Limited (SUNPHARMA) and Zydus Lifesciences Limited (ZYDUSLIFE) in the Pharmaceuticals & Healthcare sector.

SUNPHARMA

NSE: SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,801.00
1Y Return: +8.83%
52W High: ₹2,001.10
52W Low: ₹1,620.40
Annual Volatility: 19.94%
Check SUNPHARMA Trade Fees →

ZYDUSLIFE

NSE: ZYDUSLIFE
Zydus Lifesciences Limited
₹1,145.70
1Y Return: +25.16%
52W High: ₹1,215.00
52W Low: ₹891.90
Annual Volatility: 27.28%
Check ZYDUSLIFE Trade Fees →

Key Metrics Comparison Table

MetricSUNPHARMAZYDUSLIFEEdge / Winner
Current Market Price (CMP) ₹1,801.00 ₹1,145.70 —
1-Year Price Return +8.83% +25.16% ZYDUSLIFE (16.33% higher)
52-Week High ₹2,001.10 ₹1,215.00 —
52-Week Low ₹1,620.40 ₹891.90 —
30-Day Annualized Volatility 19.94% 27.28% SUNPHARMA (Steadier)
30-Day Average Daily Volume 1,593,973 1,510,992 SUNPHARMA (Higher Liquidity)
Statutory Cost to Trade ₹1 Lakh ₹118.50 ₹118.50 Identical statutory tariff

Frequently Asked Questions

Between SUNPHARMA and ZYDUSLIFE, which stock gave better returns over the last year?

ZYDUSLIFE has outperformed SUNPHARMA over the past 12 months with a gain of 25.16% compared to 8.83%.

Which stock is less volatile: SUNPHARMA or ZYDUSLIFE?

SUNPHARMA demonstrated lower price volatility (19.94% annualized) compared to ZYDUSLIFE (27.28%). Lower volatility generally indicates steadier price action during market downturns.

What is the statutory cost to buy ₹1,00,000 of SUNPHARMA vs ZYDUSLIFE?

Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).

Are SUNPHARMA and ZYDUSLIFE direct sector competitors?

Yes, both companies operate within the Pharmaceuticals & Healthcare sector in India and are actively tracked as sector peers by institutional and retail market participants.